Duojiao Wu

Dr. Duojiao Wu


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2021 in Clinical and Translational Medicine
Verified
Journal Article
Open access
PDF file
YMYan Mei
Yan Mei
WXWeiwei Xiao
Weiwei Xiao
HHHao Hu
Hao Hu
GLGuanming Lu
Guanming Lu
LCLingdan Chen
Lingdan Chen
GJGuangshuai Jia
Guangshuai Jia
Profiling heterologous cell types within tumors is essential to decipher tumor microenvironment that shapes tumor progress and determines the outcome of therapeutic response. Here, we comprehensively characterized transcriptomes of 34,037 single cells obtained from 12 treatment‐naïve patients with colorectal cancer. Our comprehensive evaluation revealed attenuated B‐cell antigen presentation, distinct regulatory T‐cell clusters with different origin and novel polyfunctional tumor associated macrophages associated with CRC. Moreover, we identified expanded XCL1+ T‐cell clusters associated with tumor mutational burden high status. We further explored the underlying molecular mechanisms by profiling epigenetic landscape and inferring transcription factor motifs using single‐cell ATAC‐seq. Our dataset and analysis approaches herein provide a rich resource for further study of the impact of immune cells and translational research for human colorectal cancer.

1 May 2012 in BMC Bioinformatics
Verified
Journal Article
Open access
PDF file
DWDuojiao Wu
Duojiao Wu
CRCatherine M Rice
Catherine M Rice
XWXiangdong Wang
Xiangdong Wang
Cancer is one of the commonest causes of patient death in the clinic and a complex disease occurring in multiple organs per system, multiple systems per organ, or both, in the body. The poor diagnoses, therapies and prognoses of the disease could be mainly due to the variation of severities, durations, locations, sensitivity and resistance against drugs, cell differentiation and origin, and understanding of pathogenesis. With increasing evidence that the interaction and network between genes and proteins play an important role in investigation of cancer molecular mechanisms, it is necessary and important to introduce a new concept of Systems Clinical Medicine into cancer research, to integrate systems biology, clinical science, omics-based technology, bioinformatics and computational science to improve diagnosis, therapies and prognosis of diseases. Cancer bioinformatics is a critical and important part of the systems clinical medicine in cancer and the core tool and approach to carry out the investigations of cancer in systems clinical medicine. "Thematic Series on Cancer Bioinformatics" gather the strength of BMC Bioinformatics, BMC Cancer, Genome Medicine and Journal of Clinical Bioinformatics to headline the application of cancer bioinformatics for the development of bioinformatics methods, network biomarkers and precision medicine. The Series focuses on new developments in cancer bioinformatics and computational systems biology to explore the potential of clinical applications and improve the outcomes of patients with cancer.

1 February 2017 in Seminars in Cancer Biology
Verified
Journal Article
Closed access
DWDuojiao Wu
Duojiao Wu
DWDiane C. Wang
Diane C. Wang
YCYunfeng Cheng
Yunfeng Cheng
MQMengjia Qian
Mengjia Qian
MZMiaomiao Zhang
Miaomiao Zhang
XWXiangdong Wang
Xiangdong Wang

1 July 2020 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
FLFangming Liu
Fangming Liu
WLWeiren Liu
Weiren Liu
SZShuang Zhou
Shuang Zhou
CYChunhui Yang
Chunhui Yang
MTMengxin Tian
Mengxin Tian
DWDuojiao Wu
Duojiao Wu
Background: Regulating T-cell metabolism is crucial for their anticancer activity. Therefore, understanding the function and metabolism of human tumor-infiltrating T cells is of broad interest and clinical importance. Methods: CD3+CD45+ T cells were sorted from adjacent area or tumor core of human hepatocellular carcinoma (HCC), then the clusters and heterogeneity of T cells were further interrogated by single-cell transcriptomic profiling. 118 surgical samples from patients with HCC were histologically examined for infiltration of CD8+ T cells in tumor and adjacent tissue. Results: Single-cell transcriptomic profiling indicated that several exhausted T-cell (Tex) populations differentially coexisted in the tumor and adjacent tissue. CD137 identifies and enriches Tex with superior effector functions and proliferation capacity. Furthermore, enhanced fatty acid-binding protein 5 (FABP5) expression along with increased mitochondrial oxidative metabolism were evident in these CD137-enriched Tex. Inhibiting FABP5 expression and mitochondrial fatty acid oxidation impaired the anti-apoptosis and proliferation of CD137-enriched Tex. These observations have been verified by generating CD137 CART. Immunohistochemistry staining on the tissue microarray of 118 patients with HCC showed intra-tumoral FABP5 high CD8+ T-cell infiltration was linked to overall and recurrence-free survival. Conclusions: The tumor microenvironment can impose metabolic restrictions on T-cell function. CD137, a costimulatory molecule highly expressed on some Tex, uses exogenous fatty acids and oxidative metabolism to mediate antitumor immunity. The immunometabolic marker FABP5 should be investigated in larger, longitudinal studies to determine their potential as prognostic biomarkers for HCC.

30 January 2024 in Experimental Cell Research
Verified
Journal Article
Closed access
HWHan Wang
Han Wang
FLFangming Liu
Fangming Liu
XWXiaoling Wu
Xiaoling Wu
GZGuiqi Zhu
Guiqi Zhu
ZTZheng Tang
Zheng Tang
YSYinghong Shi
Yinghong Shi

1 July 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
YLYan Lu
Yan Lu
EWE Wang
E Wang
YCYing Chen
Ying Chen
BZBing Zhou
Bing Zhou
JZJiejie Zhao
Jiejie Zhao
XLXiaoying Li
Xiaoying Li
Type 2 diabetes mellitus (T2DM) has become an expanding global public health problem. Although the glucocorticoid receptor (GR) is an important regulator of glucose metabolism, the relationship between circulating glucocorticoids (GCs) and the features of T2DM remains controversial. Here, we show that 17-hydroxyprogesterone (17-OHP), an intermediate steroid in the biosynthetic pathway that converts cholesterol to cortisol, binds to and stimulates the transcriptional activity of GR. Hepatic 17-OHP concentrations are increased in diabetic mice and patients due to aberrantly increased expression of Cyp17A1. Systemic administration of 17-OHP or overexpression of Cyp17A1 in the livers of lean mice promoted the pathogenesis of hyperglycemia and insulin resistance, whereas knockdown of Cyp17A1 abrogated metabolic disorders in obese mice. Therefore, our results identify a Cyp17A1/17-OHP/GR–dependent pathway in the liver that mediates obesity-induced hyperglycemia, suggesting that selectively targeting hepatic Cyp17A1 may provide a therapeutic avenue for treating T2DM.